Best Simpler Healthcare Podcasts (2024)

1
Gene therapies hold tremendous promise and uncertainty 18:41

2d ago18:41

18:41

Noelle Redmond, assistant director of clinical pharmacy services, and Danny Wallenslager, pharmacy clinical program director, discuss the encouraging and evolving treatment option of gene therapies. They also talk about how the Regence pharmacy team ensures that covered gene therapies provide a clear net benefit for health plan members.…

1
Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery? 33:55

27d ago33:55

33:55

The hardest parts of drug discovery will be vastly simplified if the mysteries of molecules and proteins can be cracked. That may be beyond human capabilities – but AI is working hard on it. In this episode of RBC’s Pathfinders in Biopharma, Noël Brown is joined by Clarissa Desjardins, CEO of Congruence, and Laksh Aithani, CEO and Co-founder of Cha…

1
How a large Idaho employer manages the rising cost of care 25:02

2M ago25:02

25:02

Dave Roberts, chief human resources officer for the West Ada School District, talks about the innovative way his district, with help from Regence and moves from the Idaho Legislature, cut the cost of premiums for employees, and what we can all do to ensure we’re getting effective, affordable health care.…

1
Shots-on-Goal Licensing Company Aims for Breakthroughs 13:52

2M ago13:52

13:52

A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.By RBC Capital Markets

1
Why Biopharma Needs to Tell Better Stories on Novel Drugs 15:31

3M ago15:31

15:31

Ronald Martell is a serial entrepreneur and biopharma veteran whose record includes the launch of Herceptin. He continues his mission to bring new drugs to patients with unmet medical needs. The CEO of Jasper Therapeutics explains his ambitions for his company’s new antibody therapy and for the future of the industry.…

1
Venture capital velocity: What’s driving renewed momentum in biotech? 35:03

3M ago35:03

35:03

In biotech, a recovery is already well underway. Expected interest rate cuts and improving valuations across public and private markets are creating a compelling environment for deals, entrances, exits, and trades to take shape. In this episode, biotech venture capital experts assess the sector’s sharper focus on funding fundamental science, evolvi…

1
Mental health crisis should be met with innovation 28:05

3M ago28:05

28:05

Dr. Mike Franz, executive medical director for behavioral health for Regence, discusses what Regence is doing to improve mental health access and what innovations are on the horizon to help more people get care.

1
Pharma Understands Phase One Data – But Does the Market? 25:30

3M ago25:30

25:30

Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.By RBC Capital Markets

1
Davern Capital sees GLP-1 Opportunities Beyond Obesity 9:39

3M ago9:39

9:39

Davern Capital’s founder, Elie Kobrin, approaches the biopharma market from a long/short perspective – but as a former doctor, he also speaks the language of medicine. He explains the fund’s approach and offers insights on hot topics in the current market.By RBC Capital Markets

1
Betting on Healthcare’s Future Hits – and Misses 14:47

4M ago14:47

14:47

As a healthcare-focused, market-neutral investor, Vince Aita stays close to new product developments with a view to identifying future successes and failures. At RBC’s Global Healthcare Conference, he offered his insights on everything from the future of obesity innovation to the impact of the IRA.By RBC Capital Markets

1
Innovation and an Aging Population Drive MedTech 16:01

4M ago16:01

16:01

The MedTech sector continues to grow in the U.S. as innovation in patient treatments and delivery meets increased demand from an aging population. Medical technology analyst Shagun Singh assesses key data points from the RBC Capital Markets’ Doctor Days events, looking at how the healthcare sector can empower investors to position themselves for fu…

1
Biopharma Investors See Opportunities in Targeted Treatments and Gene Editing 20:39

4M ago20:39

20:39

Personalized, targeted drugs and gene therapies are still at the forefront of medical innovation, as we discovered at RBC Capital Markets annual Doctor Days meetings. These insightful forums bring together key opinion leader clinicians and researchers from various therapeutic fields with institutional investors to discuss where opportunities lie, t…

1
Biotech with a Mission to Target Unmet Cancer Needs 13:37

4M ago13:37

13:37

IDEAYA’s drug development programs center around addressing unmet patient needs. Its founder tells Pathfinders in Biopharma why he believes there has never been more opportunity for breakthroughs in the fight against cancer.By RBC Capital Markets

1
How to meet the evolving health needs of seniors 16:32

4M ago16:32

16:32

Keith Bell, the CEO of Homage Senior Services, talks about how to meet the evolving health care needs of the fast-growing senior population, including the urgent need for mental health services.

1
Sounders FC partnership with Regence is part of club’s commitment to deep social impact 19:37

5M ago19:37

19:37

Ashley Fosberg, the vice president of philanthropy for Sounders FC and the executive director of RAVE Foundation, talks about the club's new partnership with Regence to improve the health of local youth, and how the club connects so profoundly to the community.

1
The M&A Pool Set to Accelerate Biotech Innovation 13:51

6M ago13:51

13:51

Q1 2024 saw a handful of IPOs in the biotech sector, and mounting excitement over novel treatments. But there are less obvious trends in play, including a shift in focus by potential buyers in pharma. RBC’s biotech investment banking team analyzes deal activity in the year to date and what it signals for the sector’s future.…

1
How PIPEs finally unblocked biotech’s funding flows 17:36

6M ago17:36

17:36

The first quarter of 2024 has seen biotech’s funding drought broken, largely through private investment in public equity (PIPE) deals. In this episode of Pathfinders in Biopharma, three members of RBC’s biotech investment banking team look at the impact of PIPEs’ success on the sector and consider how long it can last – and why it has not been univ…

1
How health equity makes care better for everyone 18:56

6M ago18:56

18:56

On this episode of the HealthChangers podcast, Michael Ann Benchoff, assistant director of health equity programs at Regence, talks about why the fight for health equity is so important. We also discussed the work that Regence is doing to make the health care system more inclusive and effective for everyone.…

1
Disruptive Forces in Healthcare: Why HCIT is finally set to bounce back 12:58

7M ago12:58

12:58

U.S. healthcare desperately needs to cut costs and improve outcomes. There is no single solution, but three disruptive forces in the digital health space are speeding change – and adding up to a healthy outlook for HCIT. Sean Dodge, Healthcare Technology Analyst, joins the podcast to unpack some of his predictions on the most impactful forces affec…

1
Will the Biotech Rebound Run into Pricing Policy Obstacles? 13:25

7M ago13:25

13:25

Drug pricing is already an issue in the U.S. election campaign. Brian Abrahams, MD and Head of Biotech Research at RBC Capital Markets joins the Pathfinders in Biopharma podcast to consider how this, together with other policy developments in the U.S. and worldwide, might affect a resurgent biotech sector.…

1
Provider contracting and health care affordability 17:42

7M ago17:42

17:42

On this episode of the HealthChangers podcast, Dr. Zak Ramadan-Jradi, vice president of network management at Regence, talks about the increasingly contentious contract negotiations between insurance carriers and hospitals, and the critical role that Regence plays in keeping health care affordable for its members.…

1
Pharmacy deserts and the rise of Ozempic and other GLP-1 drugs 19:05

8M ago19:05

19:05

On this episode of the HealthChangers podcast, Katie Lai, clinical pharmacist client manager at Regence, talks about two of the biggest trends in pharmacy today: the surge in popularity of GLP-1 drugs to lose weight, and mass pharmacy closures around the U.S. that have created “pharmacy deserts” in underserved communities.…

1
Few IPOs but plenty of follow-on for biotech in 2023 23:35

8M ago23:35

23:35

After a year of stark contrasts in the public and private equity markets for healthcare, 2024 is shaping up to be another mixed outlook. While biotech continues to bolster the market, albeit more in follow-on offerings than IPOs, and HCIT and healthcare services have tailwinds, the medtech and value-based care subsectors have challenges as well as …

1
U.S. Outlook: Will the US economy achieve a soft landing in 2024? 26:28

9M ago26:28

26:28

As the U.S. economy shows positive signs for growth, inflation, and interest rates in 2024, RBC Capital Markets’ RBC Capital Markets’ Michael Reid, Blake Gwinn, Vito Sperduto and Larry Grafstein analyze the challenges posed by consumer spending, political gridlock, and quantitative tightening. This episode was originally published on RBC's Strategi…

1
Raising Venture Capital: A New Playbook for A New Era in Biotech 36:19

10M ago36:19

36:19

In an era characterized by macro headwinds and profound market volatility, the biotech industry continues to raise capital to fuel drug development, clinical trials, and innovation. Capital raising in challenging markets comes with additional risks, leading venture capital firms and crossover investors to identify creative, unconventional deal stru…

1
What’s the connection? Jonathan Strickland reflects on a season full of Restless Ones. 11:34

11M ago11:34

11:34

With the end of another great season of The Restless Ones, Jonathan looks back on some of the guests and conversations we’ve heard from. With some truly inspiring leaders, driving change at the intersection of technology and business, he reflects on the common themes throughout these discussions and the consistent thread that connects them all - co…

1
ECM: Robust End to Year, Despite Previous Volatility 31:24

11M ago31:24

31:24

As RBC Capital Markets looks forward to a robust end to the year, John Hoffman and Jason Levitz, Co-Heads of Healthcare Equity Capital Markets explore how the firms who succeed in an especially dynamic market will be those willing to embrace new ways of thinking about unlocking value.By RBC Capital Markets

1
“Life Out Here”: Building a Stronger Community Through Network Connectivity: Rob Mills, EVP, Chief Technology, Digital Commerce, and Strategy Officer, Tractor Supply Company 24:23

11M ago24:23

24:23

The local convenience store - the cornerstone of rural America, once a one-stop shop for everything from farming and pet supplies to household goods and homemade apple pies. Fast forward to today where those same stores are providing network connectivity, technology infrastructure, and operating efficiency to bustling farming communities. With inte…

1
Laying an Innovative Foundation for Fresh Tracks and Unprecedented Experiences: Tim April, EVP and CIO, Vail Resorts 30:44

11M ago30:44

30:44

Many people visit resorts to relax and take a break from their daily routines. However, for resort managers, disconnecting from technology is not an option if they want to provide a great guest experience. To ensure guest satisfaction, including catering to their preferences, reducing wait times, and improving services, resorts need to have a const…

1
The Evolution of Technology: From Today’s Impact to Tomorrow’s Innovations: A Conversation with Phillipa Leighton-Jones, Senior Vice President of The Trust with the Wall Street Journal, and Matt Griffin ... 38:51

12M ago38:51

38:51

The word “innovation” usually evokes new ways of thinking, acting, and accelerating what’s possible, but none of that means much if it doesn’t deliver meaningful results. So, when it comes to gauging innovation’s impact, Phillipa Leighton Jones and Matt Griffin are particularly well attuned. In this special episode recorded live from Mobile World C…

1
Biotech Halftime Report: A Winding Road Ahead 17:26

1y ago17:26

17:26

Join Head of US Capital Markets Research, Mark Odendahl and biotech analysts Brian Abrahams and Gregory Renza, as they explore the dynamic biotech sector landscape in H2 2023. This episode was originally broadcast on Industries in Motion, the RBC podcast.By RBC Capital Markets

1
How Integrated Technologies and a Startup Mentality are Delivering on the Promise of Omnichannel Retail: A Conversation with Seemantini Godbole 27:17

1y ago27:17

27:17

A world where customers can buy everything they want, whenever and wherever they want isn’t 100% there—but it’s pretty close. And perhaps no company has been up for that challenge as much as Lowe’s. In this episode of The Restless Ones, I had the chance to sit down with Seemantini Godbole, EVP and CIO of Lowe’s Companies, Inc., whose early start as…

1
Empowering the Visionaries in Science: A Conversation with Mike Wondrasch, Executive Vice President and CIO, Avantor Sciences 25:28

1y ago25:28

25:28

Building blocks are a critical part of almost any private or corporate mission to reach success and scale. They let executives quickly assemble a foundation for the rest of their plans to be built on – but how are the actual building blocks getting built? Enter Avantor, who is using advancements in connectivity, data, and computing power to “set sc…

1
How Climate Change is Driving Innovation in Emergency Management: Sonia Kastner, Founder and CEO, Pano AI 30:46

1y ago30:46

30:46

As the impacts of climate change continue to escalate, public and private sector organizations find themselves in urgent need of innovation. Emergency management has been grappling with outdated tools and insufficient tech investment for decades. Companies such as Pano AI are stepping up to mitigate and better prepare for further crises with a new …

1
The Urgent Need to Address the Youth Mental Health Landscape 28:06

1y ago28:06

28:06

U.S. soccer legends and World Cup champions Briana Scurry and Dr. Sara Hess joined Andrew Callaway, Global Head of Healthcare Investment Banking at RBC Capital Markets, at this year’s RBC Global Healthcare Conference.By RBC Capital Markets

1
Delivering Last-Mile Innovation – How Clevon is Making Logistics Safer, Simpler, and More Sustainable: A Conversation with Sander Sebastian Agur 21:59

1y ago21:59

21:59

Autonomous vehicles open up a world of possibilities. From supporting more efficient roadways and improving delivery reach to mitigate labor shortages and fostering a cleaner environment, there are many use cases. So where do companies focus their efforts to make an impact? For one company, they decided to tackle one of the most challenging use cas…

1
Website Traffic Reveals Biopharma Sales Trends 10:39

1y ago10:39

10:39

A new RBC ElementsTM report, “Insights from the BioWeb,” looks at the predictive potential of website traffic as a means to uncover underappreciated market trends and sales insights. Mark Odendahl, Head of US Capital Markets Research, is joined by Brian Abrahams, Head of Biotechnology at RBC Capital Markets, to discuss the report’s findings.…

1
Gatekeepers of the Network: Educating Users to Enable Safer Innovation: Mike Anderson, Chief Digital and Information Officer, Netskope 28:02

1y ago28:02

28:02

For decades securing a corporate network was as simple as securing your home office. Global workforces, outside partners, and widespread mobile access have changed that challenge into a seemingly endless set of attack surfaces for CIOs to battle.  Whether it’s a website, SAAS app, or a program running in a corporate data center, 5G is moving that t…

1
When to Call it Quits: VCs Making Tough Decisions in a Tough Market 32:02

1y ago32:02

32:02

While the public biotech markets remain volatile, VCs continue to raise new funds. Are we witnessing a renaissance in the private capital markets? The bankruptcy rate of biotechs is historically among the lowest of US publicly traded companies, however, companies are failing and there is still a widely held belief that too many biotech companies ar…

1
The Power of Public-Private Partnerships in Shaping Education: Dr. Amy Novak, President, St. Ambrose University & Dr. Kiesha King, Senior National Education Administrator, T-Mobile for Education 28:54

1y ago28:54

28:54

Education has a dual challenge of not only keeping up with the scores of information and knowledge developed every day, it must also keep up with the changing ways we learn and consume content. Education is also too valuable of a tool to be isolated to the financially or geographically fortunate. Connected technologies, paired with 5G, are helping …

1
Spearheading More Productive Healthcare through People-Centric Process and Technology: Peter Fleischut, M.D.; Group Senior Vice President and Chief Information and Transformation Officer, NewYork-Presbyterian ... 25:43

1y ago25:43

25:43

In the medical field, the ability to transfer and interpret data in real time can be the difference between life and death. That data needs to be of high quality, moved at a high speed, and handled with the highest safeguards possible to ensure patients and their providers can receive and provide the most effective care. Building the processes that…

1
How Biotech M&A is Redefining the Strategic Landscape 25:53

1+ y ago25:53

25:53

Given current macro and regulatory headwinds, determining the optimal time to sell a biotech company is a multifaceted decision that requires careful consideration of several key factors. Hear from industry veterans Ted Love, Marc de Garidel, and Abbas Kazimi who share their insights on a new era of M&A in a panel moderated by RBC Capital Markets A…

1
Revolutionizing the Trucking Industry—A Connected Journey of Innovation: Danny Lilley, CTO, Werner Enterprises 23:06

1+ y ago23:06

23:06

Logistics are a critical component to the success of any business, and transportation companies invest heavily in mastering it. Whether it’s managing customer orders, corporate fleets, or the employees that “drive” the business forward, progress is accelerating in a 5G-connected era. Companies such as Werner Enterprises have embraced 5G-enabled tec…

1
Healthcare Should Get Ready for ‘Fast and Furious’ M&A 26:06

1+ y ago26:06

26:06

Hear from Vito Sperduto, RBC’s Co-Head of Global M&A, and his panel of RBC Capital Markets’ expert bankers on how large healthcare firms with strong balance sheets are putting cash to work — driving a ‘fast and furious’ surge of M&A activity in the second half of the year and into 2024. Learn why healthcare momentum is building and how smaller deal…

1
Innovation and Growth: Key Ingredients to Healthcare M&A 24:18

1+ y ago24:18

24:18

Compressed valuations, heightened CEO confidence, and the desire to accelerate top-line growth and scale innovation are the key factors driving healthcare M&A in 2023. As deal activity starts to accelerate, our banking experts are asking, what’s next for the sector? Listen to Pathfinders in Biopharma to find out. This episode features insights from…

1
Season 4: The Return of The Restless Ones 2:37

1+ y ago2:37

2:37

Returning for season four of the Restless Ones, an original podcast from T-Mobile for Business and iHeartRadio, host, Jonathan Strickland sits down with some of the most forward-thinking technology leaders—those at the intersection of technology and business—to explore their unique missions, challenges, and approaches to driving their organizations…

1
Biotech M&A Booms, But Have Buyouts Reached a Tipping Point? 17:04

1+ y ago17:04

17:04

In the latest episode of Pathfinders, Senior Biotechnology Analyst Gregory Renza discusses what’s driving the latest spate of biotech M&A activity — the new players and partnership dynamics that are creating what he calls “a landscape of competition” in the broader market.By RBC Capital Markets

1
Global Blood Therapeutics Commitment to Sickle-Cell Innovation 22:29

1+ y ago22:29

22:29

In this rebroadcast episode, we flash back to a previous interview with Dr. Ted W. Love, President and CEO of Global Blood Therapeutics (GBT). Dr. Love spoke with our biotechnology analyst Gregory Renza about GBT’s mission-driven culture which led to the development of Oxbryta, the company’s breakthrough sickle-cell treatment, as well as the specif…

1
Regence nurses help improve overall health care experience 28:05

1+ y ago28:05

28:05

On this episode of HealthChangers, we’re joined by a panel of health care professionals to discuss the critical role that nurses play inside and outside of Regence. This includes Dr. Donna Milavetz, senior vice president and chief medical officer at Regence, who is an internal medicine physician by training; Cheryl Carter, senior clinical transform…

1
Is This the Breakthrough Moment for Genetic Medicine? 17:25

1+ y ago17:25

17:25

Genetic medicine is poised to unlock more value for patients and investors due to disruptive technologies like mRNA, siRNA and gene editing. With an estimated 27 genetic medicines already approved, RBC’s biotechnology analyst Luca Issi explains how these technologies could be used next, and why companies able to combine the right choice of interven…

Podcasts Worth a Listen

Simpler Healthcare Podcasts

Podcasts Worth a Listen

Quick Reference Guide